Vaginal rejuvenation is an umbrella term rather than one procedure. It may include medical or conservative care, energy-based treatments, injectable or regenerative options and, for selected structural concerns, independent surgical assessment. The appropriate route depends on the symptom, likely cause, anatomy, goals and clinical assessment.

Not always. Many vaginal rejuvenation pathways are non-surgical. Surgery may be considered where structural change is the main concern or where a non-surgical option is unlikely to achieve the intended objective.

WHC does not directly perform these operations within its core non-surgical service. Where appropriate, we can refer a patient to an independent specialist practitioner for their own consultation, consent, clinical decision, procedure and aftercare.

Vaginoplasty is an internal vaginal procedure that may be considered for more significant laxity or structural change. Labiaplasty reshapes or reduces labial tissue where size, asymmetry, irritation, clothing discomfort or appearance is a concern. Perineoplasty addresses the perineal area around the vaginal opening, which may have changed after childbirth, tearing or episiotomy. An independent surgeon decides whether any procedure is appropriate.

The decision starts with the concern and likely cause. Dryness, GSM-related change, tissue quality, mild laxity or comfort concerns may be approached medically, conservatively or non-surgically. More significant structural change may justify an independent surgical opinion. No method should be selected from a treatment name alone.

Recovery varies by procedure, extent of surgery and individual healing. It is longer and more restrictive than recovery after most non-surgical options. The independent surgeon explains expected downtime, wound care, activity restrictions, sexual abstinence, review arrangements and warning signs before consent.

A reflection period may form part of the independent surgical consent process. It allows time to consider the intended benefit, alternatives, risks, recovery and whether the procedure remains the right decision.

It can. WHC can first discuss the concern and whether a non-surgical pathway or independent surgical opinion appears more appropriate. The independent practitioner then undertakes their own assessment and accepts clinical responsibility for any surgical care they provide.

Nu-V is WHC’s non-surgical CO₂ vaginal rejuvenation treatment. It uses an internal and, where indicated, external treatment approach. Detailed indications, evidence, risks, recovery and suitability are explained on the dedicated CO₂ intimate rejuvenation page.

The treatment itself is typically short and may take around 15 minutes, although the appointment is longer because preparation, consent, assessment and aftercare explanation are also required.

Depending on assessment, CO₂ treatment may be discussed for selected concerns such as vaginal dryness, tissue change, laxity, comfort or mild stress urinary leakage. These symptoms can have different causes, so the dedicated CO₂ or condition page should be read alongside clinical assessment.

No. Women may seek advice after childbirth, during perimenopause or menopause, after hormonal change, or because of comfort, sensation, tissue quality, urinary, volume, appearance or structural concerns.

A vaginal rejuvenation method may form part of a plan for some women, but dryness is a symptom rather than a diagnosis. GSM, hormonal change, infection, irritation, vulval skin conditions, medication and other causes may require different care. Read the vaginal dryness assessment page.

The vagina is the internal canal. The vulva is the external intimate area, including the labia, clitoris and vaginal opening. A concern may be internal, external or involve pelvic floor support, and this distinction affects which assessment or method may be relevant.

Not necessarily. Many concerns are better managed medically, conservatively or with a non-surgical option. Surgery is not a default escalation step; it is considered where anatomy, structural change and the intended objective make an operation the more appropriate route.

Depending on suitability, options may include vaginal moisturisers or lubricants, menopause or GSM care, pelvic floor support, O-Shot, G-Shot, vaginal or labial filler, polynucleotide injectables, selected exosome-based approaches and independent surgical assessment. Each option has a different purpose, evidence base, risk profile and recovery.

A single Nu-V treatment is £599, a triple package is £1,200 and an annual top-up is £400, as reviewed in July 2026. These prices relate to Nu-V only. Other methods and consultations are priced separately and confirmed before booking.

Yes. A free nurse telephone consultation is available as an initial confidential conversation. We normally recommend a paid doctor telephone consultation before treatment so that the concern, medical background, suitability, alternatives, risks and next step can be reviewed. An examination or further investigation may also be recommended where clinically appropriate.